Skip to content

Use of aromas in lower third molar removal surgery

Use of aromatherapy in lower third molar removal surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6z8tp94
Enrollment
Unknown
Registered
2023-07-25
Start date
2023-03-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anomalies of tooth position

Interventions

This is a randomized, double-blind, placebo-controlled clinical trial. Individuals considered eligible to participate in this study will be randomly allocated through a list of random numbers generate
E06.892

Sponsors

Centro Universitário Christus - UNICHRISTUS
Lead Sponsor
Centro Universitário Christus - UNICHRISTUS
Collaborator

Eligibility

Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Healthy individuals (American Society of Anesthesiologists - ASA I) of both genders; aged 18-35 years; who are required to remove the lower third molars; will be invited to participate in this study. In addition, the following inclusion criteria will also be adopted: (1) third unerupted mandibular molars; (2) third molars that present, in panoramic radiography, similar patterns of root formation, position and degree of impaction when comparing the right and left sides of each volunteer.

Exclusion criteria

Exclusion criteria: Volunteers who met at least one of the following criteria will be excluded: smokers; pregnant or lactating women; patients with orthodontic bands on mandibular second molars; signs of any preoperative inflammatory or infectious condition; systemic diseases; neurological disorders; patients without hearing or with auricular disorders related to the interpretation of sounds (sound frequencies), which may influence the outcomes of the present study.

Design outcomes

Primary

MeasureTime frame
To assess mean differences in clinical parameters related to pain and impact on quality of life. Pain will be assessed using the visual analogue scale. The quality of life will be evaluated through a questionnaire to be answered, called “Oral Health Impact Profile - 14” (OHIP-14), which will basically focus on negative effects.

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactEdson Cetira Filho

Universidade Federal do Ceará

edson.cetira@hotmail.com+55-085-997219653

Outcome results

None listed

Source: REBEC (via WHO ICTRP)